Meyers Michael L.
SEC CIK 1664204 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | SVP, Chief Medical Off | 23.3K | — | — | 2 | 2021-12-30 | 2022-01-31 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Meyers Michael L. made no open-market trades at SNDX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-01-31 | SNDX | Syndax Pharmaceuticals Inc | Meyers Michael L. | SVP, Chief Medical Off | J - Other | $12.39 | +1,714 | 23.3K | +8% | +$21.2K |
| D | 2022-01-03 | 2021-12-30 | SNDX | Syndax Pharmaceuticals Inc | Meyers Michael L. | SVP, Chief Medical Off | M - OptEx | $8.77 | +5,900 | 21.6K | +38% | +$51.7K |
Purchase Sale Sale after option exercise All abbreviations